Methods and compositions for treatment of central nervous system disorders


Ontology type: sgo:Patent     


Patent Info

DATE

2006-06-27T00:00

AUTHORS

BENCHERIF MEROUANE , MARRERO MARIO B

ABSTRACT

The invention provides methods of screening for substances having an effect on a nicotine receptor by contacting a cell having a nicotine receptor with a test substance; and determining any increase or decrease in phosphorylation of Janus-Activated Kinase 2 (JAK2). An increase in phosphorylation of JAK2 indicates that the test substance stimulates the nicotine receptor, and wherein a decrease in phosphorylation of JAK2 indicates that the test substance inhibits the nicotine receptor. The invention also provides screening methods for identification of substances that affect nicotine receptor activity through activity mediated by the AT2 receptor. Related pharmaceutical compositions and methods of treatment are also provided. More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "BENCHERIF MEROUANE", 
        "type": "Person"
      }, 
      {
        "name": "MARRERO MARIO B", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00196783", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048376817", 
          "https://doi.org/10.1007/bf00196783"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/375247a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037354896", 
          "https://doi.org/10.1038/375247a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35088074", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002694555", 
          "https://doi.org/10.1038/35088074"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2006-06-27T00:00", 
    "description": "

The invention provides methods of screening for substances having an effect on a nicotine receptor by contacting a cell having a nicotine receptor with a test substance; and determining any increase or decrease in phosphorylation of Janus-Activated Kinase 2 (JAK2). An increase in phosphorylation of JAK2 indicates that the test substance stimulates the nicotine receptor, and wherein a decrease in phosphorylation of JAK2 indicates that the test substance inhibits the nicotine receptor. The invention also provides screening methods for identification of substances that affect nicotine receptor activity through activity mediated by the AT2 receptor. Related pharmaceutical compositions and methods of treatment are also provided.

", "endDate": "2023-05-29", "id": "sg:patent.US-7067261-B2", "name": "Methods and compositions for treatment of central nervous system disorders", "recipient": [ { "id": "http://www.grid.ac/institutes/grid.488330.4", "type": "Organization" }, { "id": "http://www.grid.ac/institutes/grid.410427.4", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-7067261-B2" ], "sdDataset": "patents", "sdDatePublished": "2022-08-04T17:25", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/patent/patent_11.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-7067261-B2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-7067261-B2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-7067261-B2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-7067261-B2'


 

This table displays all metadata directly associated to this object as RDF triples.

44 TRIPLES      15 PREDICATES      20 URIs      9 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-7067261-B2 schema:about anzsrc-for:11
2 anzsrc-for:1109
3 schema:author N59bc92f6d2ac4d6caba733682e4664d8
4 schema:citation sg:pub.10.1007/bf00196783
5 sg:pub.10.1038/35088074
6 sg:pub.10.1038/375247a0
7 schema:datePublished 2006-06-27T00:00
8 schema:description <p num="p-0001">The invention provides methods of screening for substances having an effect on a nicotine receptor by contacting a cell having a nicotine receptor with a test substance; and determining any increase or decrease in phosphorylation of Janus-Activated Kinase 2 (JAK2). An increase in phosphorylation of JAK2 indicates that the test substance stimulates the nicotine receptor, and wherein a decrease in phosphorylation of JAK2 indicates that the test substance inhibits the nicotine receptor. The invention also provides screening methods for identification of substances that affect nicotine receptor activity through activity mediated by the AT2 receptor. Related pharmaceutical compositions and methods of treatment are also provided.</p>
9 schema:endDate 2023-05-29
10 schema:name Methods and compositions for treatment of central nervous system disorders
11 schema:recipient grid-institutes:grid.410427.4
12 grid-institutes:grid.488330.4
13 schema:sameAs https://app.dimensions.ai/details/patent/US-7067261-B2
14 schema:sdDatePublished 2022-08-04T17:25
15 schema:sdLicense https://scigraph.springernature.com/explorer/license/
16 schema:sdPublisher Ndf564584ec024e9ca747bd67273b9ae8
17 sgo:license sg:explorer/license/
18 sgo:sdDataset patents
19 rdf:type sgo:Patent
20 N0e716a8c1d0341089d85b47069548431 schema:name BENCHERIF MEROUANE
21 rdf:type schema:Person
22 N3d934deb43dc4d149671ef9ba6f93c49 rdf:first N8f2227d65648411ebe00827ae7be14ab
23 rdf:rest rdf:nil
24 N59bc92f6d2ac4d6caba733682e4664d8 rdf:first N0e716a8c1d0341089d85b47069548431
25 rdf:rest N3d934deb43dc4d149671ef9ba6f93c49
26 N8f2227d65648411ebe00827ae7be14ab schema:name MARRERO MARIO B
27 rdf:type schema:Person
28 Ndf564584ec024e9ca747bd67273b9ae8 schema:name Springer Nature - SN SciGraph project
29 rdf:type schema:Organization
30 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
31 rdf:type schema:DefinedTerm
32 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
33 rdf:type schema:DefinedTerm
34 sg:pub.10.1007/bf00196783 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048376817
35 https://doi.org/10.1007/bf00196783
36 rdf:type schema:CreativeWork
37 sg:pub.10.1038/35088074 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002694555
38 https://doi.org/10.1038/35088074
39 rdf:type schema:CreativeWork
40 sg:pub.10.1038/375247a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037354896
41 https://doi.org/10.1038/375247a0
42 rdf:type schema:CreativeWork
43 grid-institutes:grid.410427.4 schema:Organization
44 grid-institutes:grid.488330.4 schema:Organization
 




Preview window. Press ESC to close (or click here)


...